We note here that CK levels, including of the CK-MB heterodimer, have been reported to be lower44 in breast cancer patients, and more so with more advanced cancer stage, which may result in a larger longer-term effect of anthracyclines on CK-MB levels compared to hs-cTnT. The gene discussed is TNNT2; the disease is breast cancer.